Purrucker JC, et al. - Authors sought to determine the differences in clinical characteristics and severity of cerebral small vessel disease (CSVD), including cerebral microbleeds (CMBs), between patients suffering ischemic stroke (IS) or intracerebral hemorrhage (ICH) while taking novel (non-vitamin K antagonists) oral anticoagulants (NOACs). Findings did not disclose any marked variations for demographic variables and cardiovascular comorbidity. Patients with NOAC-ICH displayed similar clinical characteristics, however, a higher prevalent burden of CSVD was noted in these patients compared to NOAC-IS.